Somatostatin receptor gene expression and inhibitory effects of octreotide on primary cultures of orbital fibroblasts from Graves' ophthalmopathy (original) (raw)

Modulation of expression of somatostatin receptor subtypes in Graves' ophthalmopathy orbits: relevance to novel analogs

irina cozma

AJP: Endocrinology and Metabolism, 2007

View PDFchevron_right

Somatostatin Receptor Genes Are Expressed in Lymphocytes from Retroorbital Tissues in Graves’ Disease

Antonio Sinisi, Daniela Pasquali

The Journal of Clinical Endocrinology & Metabolism, 2002

View PDFchevron_right

Effect of Octreotide Treatment on Graves' Ophthalmopathy

Hasan Sav

Endocrine Journal, 1999

View PDFchevron_right

A Small Molecule Antagonist Inhibits Thyrotropin Receptor Antibody-Induced Orbital Fibroblast Functions Involved in the Pathogenesis of Graves Ophthalmopathy

Rebecca Bahn

The Journal of Clinical Endocrinology & Metabolism, 2013

View PDFchevron_right

Update on pathogenesis and immunology of Graves’ ophthalmopathy

Piotr Skopiński

Central European Journal of Immunology

View PDFchevron_right

Clinical implications of somatostatin-receptor scintigraphy in ophthalmic Graves' disease

Diego Ferone

European Journal of Endocrinology, 2000

View PDFchevron_right

Somatostatin and somatostatin receptors in retinal diseases

Robert Kuijpers

European Journal of Endocrinology, 2000

View PDFchevron_right

Thyrotropin Receptor Expression in Graves’ Orbital Adipose/Connective Tissues: Potential Autoantigen in Graves’ Ophthalmopathy1

Rebecca Bahn

The Journal of Clinical Endocrinology and Metabolism, 1998

View PDFchevron_right

Graves' ophthalmopathy: low-dose dexamethasone reduces retinoic acid receptor-alpha gene expression in orbital fibroblasts

Gláucia Mazeto

Archives of endocrinology and metabolism, 2018

View PDFchevron_right

Immunopathogenesis of Graves’ ophthalmopathy: The role of the TSH receptor

Rebecca Bahn

Best Practice & Research Clinical Endocrinology & Metabolism, 2012

View PDFchevron_right

Immunological Aspects of Graves’ Ophthalmopathy

shafaq mirza

BioMed Research International

View PDFchevron_right

Current Perspective on the Pathogenesis of Graves’ Disease and Ophthalmopathy

Terry Smith

Endocrine Reviews, 2003

View PDFchevron_right

Pathogenesis of Graves Ophthalmopathy: Implications for Prediction, Prevention, and Treatment

Rebecca Bahn

American Journal of Ophthalmology, 2006

View PDFchevron_right

Gene expression of estrogen receptor-alpha in orbital fibroblasts in Graves’ ophthalmopathy

Renata Luvizotto

Archives of Endocrinology and Metabolism, 2015

View PDFchevron_right

Complete Inhibition of rhTSH-, Graves' Disease IgG-, and M22-Induced cAMP Production in Differentiated Orbital Fibroblasts by a Low-Molecular-Weight TSHR Antagonist

Marcel de Gooyer

The Journal of Clinical Endocrinology & Metabolism, 2012

View PDFchevron_right

A Drug-Like Antagonist Inhibits Thyrotropin Receptor–Mediated Stimulation of cAMP Production in Graves' Orbital Fibroblasts

Elizabeth Geras Raaka

Thyroid, 2012

View PDFchevron_right

PDGF Enhances Orbital Fibroblast Responses to TSHR Stimulating Autoantibodies in Graves' Ophthalmopathy Patients

Willem van den Bosch

The Journal of Clinical Endocrinology & Metabolism, 2012

View PDFchevron_right

Alteration of Connective Tissue Growth Factor (CTGF) Expression in Orbital Fibroblasts from Patients with Graves' Ophthalmopathy

Yau-Huei Wei

PloS one, 2015

View PDFchevron_right

Gene expression of estrogen receptor-alpha in orbital fibroblasts in Graves’ ophthalmopathy

Gláucia Mazeto

Archives of Endocrinology and Metabolism, 2015

View PDFchevron_right

Somatostatin Receptor Scintigraphy Before and After Treatment with Somatostatin Analogues in Patients with Thyroid Eye Disease

ARGYRIOS DOUMAS

Thyroid, 1999

View PDFchevron_right

Pathogenesis of Graves' Ophthalmopathy: The Role of Autoantibodies

Rebecca Bahn

Thyroid, 2007

View PDFchevron_right

Somatostatin Actions via Somatostatin Receptors on the Ocular Surface Are Modulated by Inflammatory Processes

Friedrich Paulsen

Endocrinology, 2009

View PDFchevron_right

All trans retinoic acid- and N-(4-hydroxyphenil)-retinamide-induced growth arrest and apoptosis in orbital fibroblasts in Graves’ disease

valentina rossi

Metabolism-clinical and Experimental, 2003

View PDFchevron_right

The protective effect of antioxidants on orbital fibroblasts from patients with Graves' ophthalmopathy in response to oxidative stress

Yau-huei Wei

Molecular vision, 2013

View PDFchevron_right